26 completed, 4 recruiting, 2 not yet recruiting, 2 unknown. 36 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 36 | Completed 26, Recruiting 4, Not yet recruiting 2, Unknown 2, Active not recruiting 1, Enrolling by invitation 1 |
Follow Cannabis: new trials by email Literature Review of Cannabis trials Research Report on Cannabis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Hybrid Type 1 Randomized Controlled Trial of an Online and Text-Messaging Intervention to Prevent Alcohol and Cannabis Initiation, Escalation, and Consequences Among First-Year College Students Online and Text Message Intervention - Alcohol, Cannabis | Not applicable | Not yet recruiting | The University of Texas at Arlington | 800 | 2028-09-01 | 2026-10-30 |
| Allergenic Risk Assessment of Hemp Seed blood sample and skin prick tests - Cannabis, Allergens | Not applicable | Not yet recruiting | University Hospital, Angers | 35 | 2026-09-01 | 2026-06-17 |
| Developing and Strengthening Cannabis Warnings: Warning Message Testing Constituents, Cognitive Functioning, Cardiovascular Health - Cannabis, Marijuana Use | Not applicable | Completed | University of North Carolina, Chapel Hill | 1750 | 2026-07-31 | 2026-10-06 |
| A Virtual Reality Game to Prevent E-cigarette and Cannabis Vaping Virtual reality videogame intervention for vaping prevention - Cannabis, Vaping | Not applicable | Completed | Yale University | 62 | 2025-09-26 | 2026-02-17 |
| Sex Hormones Impact on Cannabis Response Cannabis, Knaster Hemp - Cannabis | Not applicable | Recruiting | Maastricht University | 21 | 2025-06-01 | 2026-02-18 |
| Nicotine and Cannabis Vape Labeling Experiment - Spring 2025 Vaping Device Labeling - Vaping, Adolescent | Not applicable | Completed | University of Southern California | 3048 | 2025-03-03 | 2026-05-22 |
| Cannabis Edibles and Simulated Driving Cannabis - Placebo Dose (0 mg), Cannabis - Low Dose (2 mg), Cannabis - Medium Dose (10 mg) - Cannabis, Driving Under the Influence | Not applicable | Completed | Centre for Addiction and Mental Health | 52 | 2024-10-01 | 2025-08-03 |
| Age Differences in the Effects of Cannabis on Simulated Driving Cannabis, Placebos - Cannabis | Not applicable | Recruiting | Centre for Addiction and Mental Health | 128 | 2024-03-27 | 2026-03-23 |
| Study on Regulated Cannabis Sales in Pharmacies Regulated cannabis from authorized pharmacies, Cannabis from the illicit market - Marijuana Smoking, Cannabis | Not applicable | Active not recruiting | University of Bern | 1177 | 2024-03-11 | 2026-05-11 |
| Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers Policy and Training Intervention, Usual and Customary Policy and Training (UC-PT) (Control) Condition - Alcoholic Intoxication, Automobile Accident | Not applicable | Enrolling by invitation | Klein Buendel, Inc. | 229 | 2024-01-15 | 2025-12-05 |
| Development and Evaluation of HighAlert High Alert, Information condition, No contact - Cannabis, Youth Drinking | Not applicable | Completed | Western University, Canada | 103 | 2023-11-01 | 2024-10-15 |
| An Integrated Program to Promote Anti-cannabis Messages A community-based network training program - Cannabis | Not applicable | Unknown | The Hong Kong Polytechnic University | 200 | 2023-09-01 | 2023-06-12 |
| Investigating Real-world Stress-related Mechanisms in Heavy Cannabis Users Intensive Day Monitoring - Cannabis Use, Cannabis | Not applicable | Completed | Yale University | 54 | 2023-06-01 | 2025-03-04 |
| Changes in Cognition and Psychiatric Disorder Symptoms During Cannabis Abstinence Using a Novel Discordant Twin Design Contingency management - Cannabis | Not applicable | Completed | University of Colorado, Denver | 146 | 2023-05-05 | 2026-08-20 |
| Joint Effort 2.0: a Mobile Application With University Students Joint Effort, Brief normative feedback and standard information - Cannabis Use, Cannabis | Not applicable | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 354 | 2023-02-08 | 2025-03-12 |
| Improving Pain Disability With the Use of Oral Cannabinoids CBD oil ( MPL-001), CDB+THC oil (MPL-005), Placebo oil - Chronic Pain, Opioid Use | Not applicable | Completed | University Health Network, Toronto | 51 | 2022-11-22 | 2026-07-22 |
| Pain Inflammation and Cannabis in HIV Receipt of Coupon for Placebo Soft-Gel Capsule, Receipt of Coupon for High THC Soft-Gel Capsule, Receipt of Coupon for Equal THC and CBD Soft-Gel Capsule - HIV Infections, Neuropathic Pain | Not applicable | Completed | Montefiore Medical Center | 35 | 2022-10-28 | 2025-11-13 |
| Transcranial Magnetic Brain Stimulation to Reduce Cannabis Use in Heavy Cannabis Users iTBS - Cannabis | Not applicable | Recruiting | Duke University | 50 | 2022-06-01 | 2026-07-13 |
| Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study CRAFT-EP, TAU - Psychosis, Substance Use | Not applicable | Completed | Mclean Hospital | 65 | 2022-05-19 | 2026-02-27 |
| Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use LPA + Fitbit Intervention - Pregnancy, Cannabis | Not applicable | Completed | Butler Hospital | 16 | 2022-01-30 | 2026-08-13 |
Showing 20 of 36. Sign in to see all of them.
Marijuana Abuse (36) · Marijuana Smoking (4) · Schizophrenia (3) · Vaping (3) · Alcohol Drinking (2) · Bipolar Disorder (2) · Cigarette Smoking (2) · Marijuana Use (2) · Mental Disorders (2) · Psychotic Disorders (2) · Substance-Related Disorders (2) · Tobacco Use (2) · Tobacco Use Disorder (2) · Adolescent Behavior (1) · Alcoholic Intoxication (1)
Chemically-Induced Disorders (36) · Mental Disorders (34) · Substance-Related Disorders (34) · Behavior (13) · Smoking (6) · Pathological Conditions, Signs and Symptoms (4) · Smoking, Non-Tobacco Products (4) · Drinking Behavior (3) · Marijuana Use (3) · Neurologic Manifestations (3) · Schizophrenia Spectrum and Other Psychotic Disorders (3) · Signs and Symptoms (3) · Alcohol-Related Disorders (2) · Bipolar and Related Disorders (2) · Immune System Diseases (2)
nabiximols (5) · Dronabinol (2) · Ethanol (2) · Transcranial Magnetic Stimulation (2) · Blood Specimen Collection (1) · Cannabidiol (1) · Electrocardiography (1) · Exercise (1) · Functional Status (1) · Medication Errors (1) · Mental Health (1) · Neuropsychological Tests (1) · Policy (1) · Reproductive Health (1) · Sex (1)
Duke University (3) · Centre for Addiction and Mental Health (2) · Klein Buendel, Inc. (2) · Mclean Hospital (2) · Medical University of South Carolina (2) · Yale University (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Butler Hospital (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Gary R Gaffney (1) · Karolinska Institutet (1) · Maastricht University (1) · Montefiore Medical Center (1) · The Hong Kong Polytechnic University (1) · The University of Texas at Arlington (1)
United States (20) · Canada (5) · Netherlands (2) · Hong Kong (1) · Slovenia (1) · Sweden (1) · Switzerland (1) · United Kingdom (1)
Bernard Le Foll, MD, PhD (1) · Christina S Meade, PhD (1) · Christine Genest, PhD (1) · Christine Wickens, PhD (1) · Damjan Osredkar, MD, PhD (1) · David Buller, PhD (1) · Deepa Camenga, MD (1) · Deepika E Slawek, MD, MPH, MS (1) · Didier Jutras-Aswad, MD MSN (1) · Don Linszen, Prof.dr. (1) · Gary G Gaffney, M.D. (1) · Gerard Schippers, Prof. dr. (1) · Gideon St. Helen, PhD (1) · Gill Woodall, PhD (1)
PMID 26019183, PMID 26144593, PMID 26257143, PMID 26889769, PMID 29435591, PMID 32070417, PMID 32707476, PMID 33341180, PMID 33823967, PMID 35032682, PMID 36642667, PMID 36750134, PMID 38416223, PMID 42671837
K23DA050808 (2), 2023 (1), K01DA050691 (1), K23DA053997 (1), K24DA048160 (1), R01AA031591 (1), R01AA033553 (1), R01CA229617 (1), R01DA025051 (1), R01DA052827 (1), R01DA058003 (1), U54CA180905 (1)